Cargando…

Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika

Detalles Bibliográficos
Autores principales: Plachot, C., Huang, C., Vemula, R., Wu, J., Lee, H.J., Anekella, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128369/
http://dx.doi.org/10.1016/j.jcv.2016.08.096
_version_ 1783516549704843264
author Plachot, C.
Huang, C.
Vemula, R.
Wu, J.
Lee, H.J.
Anekella, B.
author_facet Plachot, C.
Huang, C.
Vemula, R.
Wu, J.
Lee, H.J.
Anekella, B.
author_sort Plachot, C.
collection PubMed
description
format Online
Article
Text
id pubmed-7128369
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71283692020-04-08 Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika Plachot, C. Huang, C. Vemula, R. Wu, J. Lee, H.J. Anekella, B. J Clin Virol Article Published by Elsevier B.V. 2016-09 2016-09-12 /pmc/articles/PMC7128369/ http://dx.doi.org/10.1016/j.jcv.2016.08.096 Text en Copyright © 2016 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Plachot, C.
Huang, C.
Vemula, R.
Wu, J.
Lee, H.J.
Anekella, B.
Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika
title Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika
title_full Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika
title_fullStr Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika
title_full_unstemmed Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika
title_short Use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as Ebola, Chikungunya, Dengue-2, Norovirus GII, MERS-CoV and Zika
title_sort use of recombinant virus technology to produce non-infectious, whole process controls for emerging viruses such as ebola, chikungunya, dengue-2, norovirus gii, mers-cov and zika
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128369/
http://dx.doi.org/10.1016/j.jcv.2016.08.096
work_keys_str_mv AT plachotc useofrecombinantvirustechnologytoproducenoninfectiouswholeprocesscontrolsforemergingvirusessuchasebolachikungunyadengue2norovirusgiimerscovandzika
AT huangc useofrecombinantvirustechnologytoproducenoninfectiouswholeprocesscontrolsforemergingvirusessuchasebolachikungunyadengue2norovirusgiimerscovandzika
AT vemular useofrecombinantvirustechnologytoproducenoninfectiouswholeprocesscontrolsforemergingvirusessuchasebolachikungunyadengue2norovirusgiimerscovandzika
AT wuj useofrecombinantvirustechnologytoproducenoninfectiouswholeprocesscontrolsforemergingvirusessuchasebolachikungunyadengue2norovirusgiimerscovandzika
AT leehj useofrecombinantvirustechnologytoproducenoninfectiouswholeprocesscontrolsforemergingvirusessuchasebolachikungunyadengue2norovirusgiimerscovandzika
AT anekellab useofrecombinantvirustechnologytoproducenoninfectiouswholeprocesscontrolsforemergingvirusessuchasebolachikungunyadengue2norovirusgiimerscovandzika